RMS.VIRMS.VIVIE
Loading
EBITDA Over TimeStrong
Percentile Rank100
3Y CAGR+12.4%
5Y CAGR+24.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+12.4%/yr
vs +20.6%/yr prior
5Y CAGR
+24.3%/yr
Recent deceleration
Acceleration
-8.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$7.50B+7.2%
2024$6.99B+4.9%
2023$6.67B+26.2%
2022$5.29B+31.2%
2021$4.03B+59.5%
2020$2.53B-7.7%
2019$2.74B+9.6%
2018$2.50B+19.5%
2017$2.09B+12.8%
2016$1.85B-